Markus Germann
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 10
- Cancer Cells and Metastasis 6
- Cancer Immunotherapy and Biomarkers 2
- Cancer-related Molecular Pathways 2
-
- Genomics and Chromatin Dynamics 2
- Co-authors
- Marco Cecchini (8 shared papers)George N. Thalmann (7 shared papers)Antoinette Wetterwald (4 shared papers)Cyrill A. Rentsch (6 shared papers)Natalia Guzmán‐Ramírez (2 shared papers)Gabri van der Pluijm (2 shared papers)Jordane Malaterre (6 shared papers)Robert G. Ramsay (6 shared papers)
- Journals
- The Prostate (2 papers)Stem Cell Research (2 papers)Stem Cells (1 paper)Clinical Cancer Research (1 paper)EMBO Molecular Medicine (1 paper)
- Partner nations
- SwitzerlandAustraliaUnited States
In The Last Decade
Markus Germann
17 papers receiving 627 citations
Peers
Comparison fields: 5 of 60
- Oncology 294
- Cancer Research 120
- Immunology 138
- Pulmonary and Respiratory Medicine 179
- Molecular Biology 305
Countries citing papers authored by Markus Germann
This map shows the geographic impact of Markus Germann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Germann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Germann more than expected).
Fields of papers citing papers by Markus Germann
This network shows the impact of papers produced by Markus Germann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Germann. The network helps show where Markus Germann may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Germann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 116 | |
| 2 | 2012 | 86 | |
| 3 | 2009 | 74 | |
| 4 | 2013 | 67 | |
| 5 | 2008 | 38 | |
| 6 | 2015 | 37 | |
| 7 | 2005 | 34 | |
| 8 | 2014 | 32 | |
| 9 | 2010 | 26 | |
| 10 | 2012 | 24 | |
| 11 | 2011 | 24 | |
| 12 | 2012 | 21 | |
| 13 | 2015 | 19 | |
| 14 | 2015 | 14 | |
| 15 | 2014 | 14 | |
| 16 | Characterization and Clinical Relevance of ALDH bright Populations in Prostate Cancer | 2013 | 6 |
| 17 | 2025 | 1 |
About Markus Germann
Markus Germann is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 17 papers that have together received 633 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Prostate Cancer Treatment and Research (6 papers), Genetic factors in colorectal cancer (3 papers), Cancer, Lipids, and Metabolism (2 papers), Genomics and Chromatin Dynamics (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer-related Molecular Pathways (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Oncology (294 citations), Cancer Research (120 citations), Immunology (138 citations), Pulmonary and Respiratory Medicine (179 citations) and Molecular Biology (305 citations). Markus Germann has collaborated with scholars based in Switzerland, Australia and United States. Frequent co-authors include Marco Cecchini, George N. Thalmann, Antoinette Wetterwald, Cyrill A. Rentsch, Natalia Guzmán‐Ramírez, Gabri van der Pluijm, Jordane Malaterre, Robert G. Ramsay, Sabine Tejpar and Zoran Čulig. Their work appears in journals such as The Prostate, Stem Cell Research, Stem Cells, Clinical Cancer Research and EMBO Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.